Outlook and Conclusion on Natural Capsules
- At the current market price of Rs73.00 the stock P/E ratio is at 5.96 x FY15E and 5.22 x FY16E respectively.
- Earnings per share (EPS) of the company for the earnings for FY15E and FY16E are seen at Rs12.25 and Rs13.99 respectively.
- Net Sales and Operating Profit of the company are expected to grow at a CAGR of 14% and 9% over 2013 to 2016E respectively.
- On the basis of EV/EBITDA, the stock trades at 3.14 x for FY15E and 2.71 x for FY16E.
- Price to Book Value of the stock is expected to be at 0.76 x and 0.66 x respectively for FY15E and FY16E.
- We recommend ‘Buy’ in this particular scrip with a target price of Rs85.00 for Medium to Long term investment.
Natural Capsules: An overview
Natural Capsules Limited is a well-equipped modern manufacturing plant to manufacture Hard Gelatin Capsule shells, Hard Cellulose Capsule shells and Pharmaceutical Dosage Forms in Capsule Dosage Form. The company is also engaged in formulating the pharmaceutical dosage forms in Capsule dosage form, both Pharma and Neutraceutical Products. It offers hard gelatin capsule shells; hard cellulose capsule shells; and bovine spongiform encephalopathy and transmissible spongiform encephalopathy free gelatin, shiny gelatin, sodium lauryl sulfate free gelatin, fortified gelatin, sweet gelatin, fast release gelatin, and printed gelatin/cellulose capsule shells. It is also involved in formulating pharmaceutical dosage forms in capsule dosage form, including pharma and neutraceutical products. In addition, it offers various services comprising contract research in synthetic chemistry, dosage development, and dossier in CTD format, manufacture of API’s and finished dosage forms, development of dossiers/ANDA for products, and contract research an
No comments :
Post a Comment